Healthcare
Labcorp Holdings Inc.(LH)
Live Price
Offline$255.82
-1.44% today
1Y Change
+2.34%
Window
Jun 25, 2025 โ Jun 16, 2026
- Market Cap
- $21.17B
- Revenue Growth
- +7.2%
- EPS Growth
- +18.6%
- Dividend Yield
- 1.1%
Coverage: 245 bars ยท Jun 25, 2025 โ Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Labcorp Holdings Inc. (LH) is a Healthcare stock with a market cap of $21.17B and listed on NYSE. The stock last traded around $255.82 and up 2.3% across the available one-year price window (Jun 25, 2025 โ Jun 16, 2026). Baseline metrics include revenue growth of +7.2%, EPS growth of +18.6%, a dividend yield of 1.1%. What stands out right now is revenue +7.2%, EPS +18.6%, free cash flow +10.0% with operating margin 11.0% and ROIC 7.5%. The dividend is present but secondary, with a yield around 1.1%. Valuation is more restrained than many high-expectation growth names at P/E 22.5 and price/sales 1.5. Stock Foundry combines LH price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Near sector median
+7.2% vs +7.6% peer median
Operating Margin
Below sector median
+11.0% vs +19.4% peer median
P/E
Below sector median
22.5 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 30, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +7.2% and EPS at +18.6%, with operating margin around 11.0%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 1.1%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +0.5% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 30, 2026 | โ | -0.4% | +0.5% | +1.3% |
2026 Feb 17, 2026 | +3.0% | +0.8% | +3.8% | -2.2% |
2025 Oct 28, 2025 | +1.2% | -4.4% | -2.8% | +3.9% |
Benchmark Edge
LH vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
LH
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
LH Max Drawdown
-15.22%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for LH and SPY.
Company Overview
Labcorp Holdings Inc.
New York Stock Exchange
Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.
- Leadership
- Adam H. Schechter
- IPO Date
- Mar 29, 1990
- Employees
- 60.9k
- Street Address
- 358 South Main Street
- Mailing
- Burlington, NC, 27215
- Region
- Burlington, NC, US
- Reporting Currency
- USD
- Investor Line
- 336 229 1127
- Last Updated
- May 1, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 22.5
- EV/EBITDA
- 13.2
- Price/Sales
- 1.5
- Price/Book
- 2.4
Growth
- Revenue
- +7.2%
- EPS
- +18.6%
- Free Cash Flow
- +10.0%
Profitability
- Gross Margin
- 27.8%
- Operating Margin
- 11.0%
- Net Margin
- 6.7%
- ROE
- 10.9%
- ROIC
- 7.5%
Balance Sheet
- Debt/Equity
- 0.83
- Current Ratio
- 1.73
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.